Total Payments
$2,034
2024 Payments
$243.35
Companies
6
Transactions
16
Medicare Patients
7,079
Medicare Billing
$5.2M
Payment Breakdown by Category
Food & Beverage$1,250 (61.4%)
Travel$765.09 (37.6%)
Gifts$19.40 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,250 | 13 | 61.4% |
| Travel and Lodging | $765.09 | 2 | 37.6% |
| Gift | $19.40 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $1,030 | 4 | $0 (2023) |
| Genentech USA, Inc. | $414.04 | 4 | $0 (2024) |
| Genentech, Inc. | $277.58 | 4 | $0 (2018) |
| Regeneron Pharmaceuticals, Inc. | $195.63 | 2 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $97.50 | 1 | $0 (2022) |
| Carl Zeiss Meditec AG | $19.40 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $243.35 | 2 | Genentech USA, Inc. ($125.20) |
| 2023 | $985.87 | 4 | NOVARTIS PHARMACEUTICALS CORPORATION ($908.39) |
| 2022 | $218.70 | 2 | Genentech USA, Inc. ($121.20) |
| 2020 | $19.40 | 1 | Carl Zeiss Meditec AG ($19.40) |
| 2019 | $216.50 | 2 | Novartis Pharmaceuticals Corporation ($121.75) |
| 2018 | $256.07 | 3 | Genentech, Inc. ($183.18) |
| 2017 | $94.40 | 2 | Genentech, Inc. ($94.40) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $125.20 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/11/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $118.15 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/22/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Travel and Lodging | In-kind items and services | $540.22 | General |
| 09/22/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Travel and Lodging | In-kind items and services | $224.87 | General |
| 09/22/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Food and Beverage | In-kind items and services | $143.30 | General |
| 05/18/2023 | Regeneron Pharmaceuticals, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $77.48 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/10/2022 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $97.50 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/20/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $121.20 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/03/2020 | Carl Zeiss Meditec AG | None Specified (Medical Supply) | Gift | In-kind items and services | $19.40 | General |
| 10/13/2019 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $94.75 | General |
| Category: Ophthalmology | ||||||
| 10/11/2019 | Novartis Pharmaceuticals Corporation | BUPARLISIB (Drug) | Food and Beverage | In-kind items and services | $121.75 | General |
| 11/05/2018 | Genentech, Inc. | Lucentis (Biological), Non-Covered Product | Food and Beverage | In-kind items and services | $114.55 | General |
| Category: Ophthalmology | ||||||
| 10/26/2018 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $72.89 | General |
| Category: Ophthalmology | ||||||
| 02/12/2018 | Genentech, Inc. | Lucentis (Biological), Non-Covered Product | Food and Beverage | In-kind items and services | $68.63 | General |
| Category: Ophthalmology | ||||||
| 09/25/2017 | Genentech, Inc. | Lucentis (Biological), Non-Covered Product | Food and Beverage | In-kind items and services | $56.00 | General |
| Category: Ophthalmology | ||||||
| 06/06/2017 | Genentech, Inc. | Non-Covered Product (Drug) | Food and Beverage | In-kind items and services | $38.40 | General |
| Category: None | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,694 | 10,489 | $3.2M | $1.2M |
| 2022 | 13 | 1,853 | 7,043 | $3.2M | $1.3M |
| 2021 | 13 | 1,742 | 7,146 | $3.2M | $1.3M |
| 2020 | 14 | 1,790 | 7,555 | $3.4M | $1.4M |
Total Patients
7,079
Total Services
32,233
Medicare Billing
$5.2M
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 71 | 820 | $1.2M | $568,255 | 46.2% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 41 | 1,116 | $669,600 | $201,059 | 30.0% |
| 67028 | Injection of drug into eye | Office | 2023 | 264 | 1,227 | $451,170 | $121,678 | 27.0% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 15 | 3,660 | $219,600 | $106,377 | 48.4% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 177 | 852 | $127,800 | $61,563 | 48.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 364 | 832 | $178,915 | $55,088 | 30.8% |
| 92134 | Imaging of retina | Office | 2023 | 456 | 1,666 | $183,192 | $51,120 | 27.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 123 | 123 | $52,890 | $15,503 | 29.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 47 | 54 | $16,550 | $4,901 | 29.6% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 42 | 42 | $17,790 | $4,710 | 26.5% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 17 | 18 | $12,760 | $3,653 | 28.6% |
| 92250 | Photography of the retina | Office | 2023 | 61 | 61 | $7,640 | $1,659 | 21.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 18 | $2,455 | $799.79 | 32.6% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 78 | 926 | $1.4M | $666,726 | 48.0% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 41 | 1,233 | $739,800 | $273,203 | 36.9% |
| 67028 | Injection of drug into eye | Office | 2022 | 264 | 1,220 | $424,980 | $120,742 | 28.4% |
| J7999 | Compounded drug, not otherwise classified | Office | 2022 | 180 | 826 | $123,900 | $59,425 | 48.0% |
| 92134 | Imaging of retina | Office | 2022 | 465 | 1,616 | $177,579 | $49,310 | 27.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 355 | 687 | $130,530 | $46,708 | 35.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 107 | 107 | $46,010 | $13,337 | 29.0% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 138 | 176 | $40,656 | $9,798 | 24.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 67 | 71 | $19,880 | $6,495 | 32.7% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 60 | 60 | $27,600 | $6,387 | 23.1% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2022 | 12 | 15 | $14,708 | $3,052 | 20.7% |
| 92250 | Photography of the retina | Office | 2022 | 72 | 73 | $11,315 | $1,983 | 17.5% |
About Dr. Paul Tlucek, MD
Dr. Paul Tlucek, MD is a Retina Specialist healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1982800470.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Tlucek, MD has received a total of $2,034 in payments from pharmaceutical and medical device companies, with $243.35 received in 2024. These payments were reported across 16 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($1,250).
As a Medicare-enrolled provider, Tlucek has provided services to 7,079 Medicare beneficiaries, totaling 32,233 services with total Medicare billing of $5.2M. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Retina Specialist
- Other Specialties Retina Specialist, Internal Medicine
- Location Portland, OR
- Active Since 06/22/2007
- Last Updated 10/01/2024
- Taxonomy Code 207WX0107X
- Entity Type Individual
- NPI Number 1982800470
Products in Payments
- Lucentis (Biological) $406.82
- EYLEA (Biological) $174.98
- Vabysmo (Drug) $125.20
- BUPARLISIB (Drug) $121.75
- VABYSMO (Drug) $121.20
- EYLEA HD (Biological) $118.15
- Non-Covered Product (Drug) $38.40
- None Specified (Medical Supply) $19.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.